Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Enrolling by invitation Not applicable

Recreational Badminton, Sleep and Melatonin

NCT07906184 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-03-24
Last updated
2026-10-30

Condition(s) studied

Sedentary Behavior

Investigational drug(s) / intervention(s)

Recreational BadmintonTo be used for comparison purposes. There is no intervention.

Recreational Badminton: It is well established that regular exercise has positive effects on both physiological and psychological health. Existing research indicates that regular physical activity reduces sleep latency, increases sleep duration, and improves overall sleep quality. Furthermore, exercise can contribute to the regulation of circadian rhythms by influencing the secretion of the hormone melatonin. Consequently, experts recommend exercise programs to individuals to improve their health status, sleep, and quality of life. It has been noted that exercise facilitates falling asleep, promotes deeper sleep, and enhances how individuals feel upon waking in the morning. However, studies directly comparing melatonin secretion and sleep quality between individuals who engage in recreational exercise and those who do not remain limited. This study aims to conduct a comparative analysis between these two groups to more clearly elucidate the effects of recreational exercise on sleep. The findings are expected

To be used for comparison purposes. There is no intervention.: Saliva samples will be collected from this group without any intervention.

Study summary

Poor sleep quality is increasingly prevalent among physically inactive young adults and is associated with adverse physical and mental health outcomes. Regular physical activity may improve sleep quality and circadian regulation, although evidence regarding recreational sports remains limited. This randomized controlled trial investigated the effects of a 4 week supervised recreational badminton program on sleep quality and salivary melatonin concentrations in physically inactive young adults. Participants were randomly assigned to either a badminton intervention group or a control group. Sleep quality and salivary melatonin levels were assessed before and after the intervention.

Eligibility

Sex
ALL
Min age
18 Years
Max age
30 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Individuals who agree to participate in the study * Healthy university students aged 18-30 Exclusion Criteria: * Individuals who do not agree to participate in the study * Individuals with any chronic disease * Individuals with any health condition that would prevent them from exercising

Primary outcome measure(s)

  • Salivary Melatonin Measurements — 3 MONTHS
    Melatonin levels will be determined using saliva samples collected from participants at three different times of the day (8:00 AM, 8:00 PM, and 12:00 AM). Analyses will be performed using the Enzyme-Linked Immunosorbent Assay (ELISA) method.

Trial sites (1)

FacilityCityRegionStatus
Inonu University Malatya Turkey (Türkiye)
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07906184 on ClinicalTrials.gov ↗ ← All trials in Turkey